The invention provides an RORγ receptor agonist comprising a compound of formula (I), wherein the variables are as defined herein. These compounds are analogous to known RORγ receptor antagonists. The invention further provides a method of activating -the nuclear receptor RORγ, comprising -contacting the RORγ with an effective amount or concentration of a compound of the invention; and a method of treating cancer in a patient, comprising administering to the patient an effective dose of a compound of the invention.
本发明提供了一种含有公式(I)化合物的RORγ受体激动剂,其中变量如本文所述定义。这些化合物与已知的RORγ受体
拮抗剂类似。本发明进一步提供了一种激活核受体RORγ的方法,包括以有效量或浓度与RORγ接触本发明化合物;以及一种在患者中治疗癌症的方法,包括向患者施用本发明化合物的有效剂量。